Cargando…

The Japanese version of the National Cancer Institute’s patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE): psychometric validation and discordance between clinician and patient assessments of adverse events

BACKGROUND: The Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) was developed by the National Cancer Institute as an adverse event assessment system to evaluate patients’ symptoms, which tend to be underestimated in cancer clinical trials. The aim...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kawaguchi, Takashi, Azuma, Kanako, Sano, Motohiko, Kim, Soan, Kawahara, Yosuke, Sano, Yoko, Shimodaira, Tomohide, Ishibashi, Keiichiro, Miyaji, Tempei, Basch, Ethan, Yamaguchi, Takuhiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2018
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5934922/ https://www.ncbi.nlm.nih.gov/pubmed/29757309 http://dx.doi.org/10.1186/s41687-017-0022-5

Ejemplares similares

Japanese translation and linguistic validation of the US National Cancer Institute’s Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)
por: Miyaji, Tempei, et al.
Publicado: (2017)

Cultural adaptation of the Italian version of the Patient-Reported Outcomes Common Terminology Criteria for Adverse Event (PRO-CTCAE®)
por: Caminiti, Caterina, et al.
Publicado: (2022)

Missing data strategies for the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) in Alliance A091105 and COMET-2
por: Mazza, Gina L., et al.
Publicado: (2021)

Swahili translation and cultural adaptation of the pediatric patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE)
por: Schroeder, Kristin M., et al.
Publicado: (2023)

Linguistic validation of the simplified Chinese version of the US National Cancer Institute’s patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE™)
por: KKF, Cheng, et al.
Publicado: (2020)

Correction to: Missing data strategies for the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) in Alliance A091105 and COMET-2
por: Mazza, Gina L., et al.
Publicado: (2021)

Routine Surveillance of Chemotherapy Toxicities in Cancer Patients Using the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)
por: Wang, Tian Qi, et al.
Publicado: (2018)

Feasibility and acceptability of electronic symptom surveillance with clinician feedback using the Patient-Reported Outcomes version of Common Terminology Criteria for Adverse Events (PRO-CTCAE) in Danish prostate cancer patients
por: Baeksted, Christina, et al.
Publicado: (2017)

Dutch translation and linguistic validation of the U.S. National Cancer Institute’s Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE™)
por: Veldhuijzen, Evalien, et al.
Publicado: (2020)

Mode equivalence and acceptability of tablet computer-, interactive voice response system-, and paper-based administration of the U.S. National Cancer Institute’s Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)
por: Bennett, Antonia V., et al.
Publicado: (2016)

Registry study of immune-related adverse events using electronic patient-reported outcome in patients with cancer receiving immune checkpoint inhibitors: protocol for a multicentre cohort study
por: Hirata, Taiki, et al.
Publicado: (2023)

Protocol for the ASTRO study (SSOP-01): a multicentre prospective cohort study investigating adverse events based on electronic patient-reported outcomes in patients with breast cancer after adjuvant chemotherapy
por: Kuniyoshi, Ouki, et al.
Publicado: (2023)

Veterinary Cooperative Oncology Group—Common Terminology Criteria for Adverse Events (VCOG‐CTCAE v2) following investigational therapy in dogs and cats
por: LeBlanc, Amy K., et al.
Publicado: (2021)

Validity and reliability of the simplified Chinese patient-reported outcomes version of the common terminology criteria for adverse events
por: Yang, Shan-Shan, et al.
Publicado: (2021)

Software for Administering the National Cancer Institute’s Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events: Usability Study
por: Schoen, Martin W, et al.
Publicado: (2018)

Adverse Events of Antiepileptic Drugs Using Indonesian Version of Liverpool Adverse Events Profile
por: Budikayanti, Astri, et al.
Publicado: (2018)

Clinician and Patient Reporting of Symptomatic Adverse Events in Cancer Clinical Trials: Using CTCAE and PRO-CTCAE(®) to Provide Two Distinct and Complementary Perspectives
por: Minasian, Lori M, et al.
Publicado: (2022)

Establishing a common metric for patient-reported outcomes in cancer patients: linking patient reported outcomes measurement information system (PROMIS), numerical rating scale, and patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE)
por: Lee, Minji K., et al.
Publicado: (2020)

Linguistic Validation of the US National Cancer Institute’s Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events in Korean
por: Cho, Juhee, et al.
Publicado: (2019)

Correction to: Establishing a common metric for patient-reported outcomes in cancer patients: linking patient reported outcomes measurement information system (PROMIS), numerical rating scale, and patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE)
por: Lee, Minji K., et al.
Publicado: (2021)

Correction to: Establishing a common metric for patient-reported outcomes in cancer patients: linking patient reported outcomes measurement information system (PROMIS), numerical rating scale, and patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE)
por: Lee, Minji K., et al.
Publicado: (2023)

Statin-Associated Muscular and Renal Adverse Events: Data Mining of the Public Version of the FDA Adverse Event Reporting System
por: Sakaeda, Toshiyuki, et al.
Publicado: (2011)

Data Mining of the Public Version of the FDA Adverse Event Reporting System
por: Sakaeda, Toshiyuki, et al.
Publicado: (2013)

Adverse event profiles of dipeptidyl peptidase-4 inhibitors: data mining of the public version of the FDA adverse event reporting system
por: Huang, Jing, et al.
Publicado: (2020)

Terminology integration and inconsistency identification of adverse event terminology for Japanese medical devices using SPARQL
por: Yagahara, Ayako, et al.
Publicado: (2022)

Identifying symptomatic adverse events using the patient‐reported outcomes version of the common terminology criteria for adverse events in patients with non‐small cell lung cancer with epidermal growth factor receptor exon 20 insertion mutations
por: Zhu, Yanyan, et al.
Publicado: (2022)

Adverse Event Profiles of Platinum Agents: Data Mining of the Public Version of the FDA Adverse Event Reporting System, AERS, and Reproducibility of Clinical Observations
por: Sakaeda, Toshiyuki, et al.
Publicado: (2011)

Use and misuse of common terminology criteria for adverse events in cancer clinical trials
por: Zhang, Sheng, et al.
Publicado: (2016)

Cancer Chemotherapy-Induced Oral Adverse Events: Oral Dysesthesia and Toothache - A Retrospective Study
por: Hino, Shunsuke, et al.
Publicado: (2021)

Developing a Mobile Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Administration System to Capture Postradiation Toxicity in Oncology: Usability and Feasibility Study
por: Underwood, Jody, et al.
Publicado: (2022)

Adverse Event Profiles of 5-Fluorouracil and Capecitabine: Data Mining of the Public Version of the FDA Adverse Event Reporting System, AERS, and Reproducibility of Clinical Observations
por: Kadoyama, Kaori, et al.
Publicado: (2011)

Selecting a Subset Based on the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events for Patient-Reported Symptom Monitoring in Lung Cancer Treatment: Mixed Methods Study
por: Veldhuijzen, Evalien, et al.
Publicado: (2021)

Surveillance of Symptom Burden Using the Patient-Reported Outcome Version of the Common Terminology Criteria for Adverse Events in Patients With Various Types of Cancers During Chemoradiation Therapy: Real-World Study
por: Kang, Danbee, et al.
Publicado: (2023)

Omeprazole- and Esomeprazole-associated Hypomagnesaemia: Data Mining of the Public Version of the FDA Adverse Event Reporting System
por: Tamura, Takao, et al.
Publicado: (2012)

Translation, Cross-Cultural Adaptation, and Measurement Properties of the Portuguese Version of the Global Trigger Tool for Adverse Events
por: Pierdevara, Ludmila, et al.
Publicado: (2020)

The Geneva Event (Short version)
Publicado: (2020)

Hypersensitivity reactions to anticancer agents: Data mining of the public version of the FDA adverse event reporting system, AERS
por: Kadoyama, Kaori, et al.
Publicado: (2011)

Development of the Japanese version of the Intensive Care Unit Trigger Tool to detect adverse events in critically ill patients
por: Aikawa, Gen, et al.
Publicado: (2021)

Linking the European Organisation for Research and Treatment of Cancer Item Library to the Common Terminology Criteria for Adverse Events
por: Gilbert, Alexandra, et al.
Publicado: (2022)

Patient-reported outcomes version of the common terminology criteria for adverse events and quality-of-life linear analogue self-assessment in breast cancer patients receiving radiation therapy: single-institution prospective registry
por: Thorpe, C. S., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_375j4lh8d6hmt91ard93bek87t